Opioid
Geriatric drug overdose deaths in US quadrupled over 20 years
From 2002 to 2021, the rate of drug overdose death among people aged 65 years or older quadrupled, according to data published in JAMA Psychiatry.
Incentive program increases buprenorphine treatment in ED patients with opioid addiction
Patients who attended a Pennsylvania hospital ED implementing a financial incentive program to increase opioid use disorder treatment engagement were more likely to start buprenorphine compared with patients at other hospitals.
FDA limit on acetaminophen dosage linked to fewer hospitalizations, cases of liver failure
A 2011 FDA mandate, which limited acetaminophen dosage to 325 mg/tablet in prescription acetaminophen and opioid products, correlated with a decrease in yearly hospitalizations and cases of acute liver failure related to toxicity.
FDA approves over-the-counter Narcan nasal spray for opioid overdoses
The FDA on Wednesday approved 4 mg Narcan nasal spray for over-the-counter use as an emergency treatment for opioid overdose. It is the first naloxone product to be available without a prescription.
Drug overdose deaths in 2020 highlight racial disparities
There were more drug overdose deaths in 2020 than anticipated based on trends from 2013 to 2019, with more fatalities among Black people compared with white people, according to findings published in PLOS Global Public Health.
The Song of Our Scars: The Untold Story of Pain, by Haider Warraich, MD
In this issue of Healio Rheumatology, we have touched upon a topic that is incredibly important not only for our field of rheumatology, but for health care in general — namely, the issue of chronic pain and all its dimensions.
Chronic pain in rheumatology: Is it a problem of mind or body?
This month, our featured roundtable assembled an esteemed panel of experts on pain to help unravel the complexities we face with our patients who have chronic unresponsive pain, often in the setting of systemic immune-mediated disorders.
Chronic pain, opioids and the ‘false dream of mass anesthesia’
For more than a decade, the medical community as a whole, and particularly the field of rheumatology, has been trying to move away from opioids for the management of chronic pain — with varying degrees of success.
Bupropion may promote cocaine abstinence in some opioid users
In addition to a financial incentive, bupropion may help some people being treated for opioid use disorder to stop using cocaine, according to findings published in JAMA Network Open.
Outreach program after opioid overdose decreases later overdose death
Participation in an outreach program following a nonfatal opioid overdose was associated with lower risk for later overdose death, according to data published in JAMA Psychiatry.